Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Heath

Showing results (891-900 of 916) with videos related to

Pageof 92
Sort By:
Biorxiv : the Preprint Server for Biology|August 9, 2020
Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesYapeng Su, Daniel Chen, Christopher Lausted, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II TrialPatrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature Immunology|August 26, 2020
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammationSusanna S Ng, Fabian De Labastida Rivera, Juming Yan, et al.
Cell|November 10, 2020
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Yapeng Su, Daniel Chen, Dan Yuan, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population LevelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
Frontiers in Immunology|January 22, 2025
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
Pageof 92

Showing results (891-900 of 916) with videos related to

Sort By:
Pageof 92
Biorxiv : the Preprint Server for Biology|August 9, 2020
Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesYapeng Su, Daniel Chen, Christopher Lausted, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Immunity|September 30, 2021
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19Benjamin Krämer, Rainer Knoll, Lorenzo Bonaguro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II TrialPatrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature Immunology|August 26, 2020
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammationSusanna S Ng, Fabian De Labastida Rivera, Juming Yan, et al.
Cell|November 10, 2020
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Yapeng Su, Daniel Chen, Dan Yuan, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population LevelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
Frontiers in Immunology|January 22, 2025
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
Pageof 92